Mr. Chengming Ding, a partner at Beijing Zhonglun W&D (Hangzhou) Law Firm, specializes in capital markets & securities, corporate & M&A, and dispute resolution. With extensive legal experience in securities issuance & listing as well as corporate M&A restructuring, he has participated in numerous projects including corporate restructurings, enterprise reorganizations, domestic/overseas IPOs, listed company mergers & restructurings, and private placements across industries such as chemicals, pharmaceuticals, power generation, and related sectors.

Working Experience

• 2019–2025   Beijing Zhonglun W&D (Hangzhou) Law Firm, Lawyer
• 2025–Present   Beijing Zhonglun W&D (Hangzhou) Law Firm, Partner

Achievements

IPO

Advised on IPOs for Deye Co., Ltd. (SH 605117), Yema Battery (SH 605378), and Chengda Pharmaceuticals (SZ 301201).

Major Asset Restructuring of Listed Companies

Represented Stars Technology (SZ 300256) in its major asset restructuring and supplementary fundraising project.

Advised Petpal Pet Nutrition (SZ 300673) on its acquisition of Shanghai Hachong.

Equity/Bond Issuance for Listed Companies

Facilitated Petpal Pet Nutrition’s (SZ 300673) 2020 private placement and Stars Technology’s (SZ 300256) 2021 private placement.

Advised Petpal Pet Nutrition (SZ 300673) on its 2021 convertible bond issuance.

Equity Incentive Plans

Provided legal services for employee equity incentive plans at Chengda Pharmaceuticals, Guangxing Health, and Tianjie Industrial.

Corporate Bond Issuance for Non-Listed Companies

Advised Zhejiang Daily Press Group on its 2021 medium-term notes and 2021/2025 super short-term commercial paper issuances.

NEEQ (New Third Board)

Supported Mule Medical (NEEQ 832652) and Chengtai Technology (NEEQ 834948) in their NEEQ listing projects.

Shanghai University of Political Science and Law ，Master of Law

PRC Lawyer’s Practicing Qualification

Chinese and English